KBC Group’s Agilon Health AGL Stock Holding History

KBC Group’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-648	Closed	-$70K	–	1716
2025 Q1	$70K	Buy	+648	New	+$56.4K	﹤0.01%	1672
2024 Q4	–	Sell	-385	Closed	-$38K	–	1833
2024 Q3	$38K	Hold	385	–	–	﹤0.01%	1794
2024 Q2	$63K	Hold	385	–	–	﹤0.01%	1471
2024 Q1	$59K	Buy	385 +132	+52%	+$22K	﹤0.01%	1449
2023 Q4	$79K	Hold	253	–	–	﹤0.01%	1208
2023 Q3	$112K	Buy	+253	New	+$114K	﹤0.01%	966

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

KBC Group's AGL Position: Q2 2025 in Review

KBC Group sold out of Agilon Health (AGL) in Q2 2025, closing a stake of 648 shares — an estimated $70K sold.

KBC Group first reported a position in AGL in Q3 2023 and held it in 6 quarters. The position peaked at $112K in Q3 2023. 205 funds tracked by Wall St. Rank hold AGL as of Q2 2025.

KBC Group reported no remaining Agilon Health position as of Q2 2025 after selling out during the quarter.
KBC Group sold 648 Agilon Health shares in Q2 2025, an estimated $70K.
KBC Group first reported a position in Agilon Health in Q3 2023 and held it in 6 quarters.
KBC Group's Agilon Health position peaked at $112K in Q3 2023.
205 funds tracked by Wall St. Rank held Agilon Health as of Q2 2025.

Based on KBC Group's 13F filing for Q2 2025, filed 8 Aug 2025.